Log in
/
Register
Home
Overview
Upload / Manage Data
Browse / Search Studies
Analyze Studies
Tutorials
FAQ
Data Repository
Overview
Upload / Manage Studies
Browse / Search Studies
Analyze Studies
Data Sharing Policy
Tutorials
FAQ
Databases
Overview
Metabolite Database
Human Metabolome Gene/Protein Database (MGP)
RefMet: Reference List of Metabolite Names
External Metabolomics Databases (Links)
Protocols
Overview
General Protocols
Study-specific Protocols
Tools
Overview
Load and analyze your own dataset
Analyze Studies
MS Searches
Structure drawing
REST Service
External Tools (Links)
About
Overview
Publishing Partners
How to Cite
How to Link
Terms of Use
Personnel
Contact
Sitemap
Search
Keyword Search
Advanced Searches
Clustering data with hclust algorithm for (Study ST000344)
(Analysis AN000557)
Metabolite
Structure
F1
F2
PE (36:2)
ME118736
0.87
1.13
1_TG (17:0/17:1/17:0)-d5 iSTD
ME118707
1.26
0.74
Ceramide (d42:1)
ME118709
1.28
0.72
Ceramide (d40:1)
ME118708
1.29
0.71
PC (p-34:3) or PC (o-34:4)
ME118728
1.29
0.71
SM (d40:0)
ME118742
1.30
0.70
SM (d42:0)
ME118743
1.31
0.69
1_DG (12:0/12:0/0:0) iSTD
ME118694
1.37
0.63
1_DG (18:1/2:0/0:0) iSTD
ME118696
1.33
0.67
PC (42:1)
ME118726
1.12
0.88
PC (40:1)
ME118724
1.12
0.88
1_LPE (17:1) iSTD
ME118698
1.12
0.88
1_MG (17:0/0:0/0:0) iSTD
ME118701
1.12
0.88
PE (34:2)
ME118734
1.13
0.87
1_PE (17:0/17:0) iSTD
ME118703
1.13
0.87
PC (p-36:3) or PC (o-36:4)
ME118731
1.13
0.87
SM (d34:0)
ME118741
1.14
0.86
PE (34:1)
ME118733
1.14
0.86
PC (p-36:0) or PC (o-36:1)
ME118729
1.14
0.86
PC (32:1)
ME118719
1.14
0.86
PC (30:0)
ME118717
1.14
0.86
1_Cholesterol d7 iSTD
ME118691
1.14
0.86
Lactosylceramide (d18:1/24:1(15Z))
ME118715
1.14
0.86
PC (36:1)
ME118721
1.15
0.85
1_Sphingosine (d17:1) iSTD
ME118705
1.15
0.85
PC (32:3)
ME118720
1.15
0.85
GlcCer (d40:1)
ME118712
1.20
0.80
PC (28:0)
ME118716
1.21
0.79
PE (p-32:1) oe PE (o-32:2)
ME118737
1.21
0.79
PE (36:1)
ME118735
1.19
0.81
GlcCer (d42:1)
ME118713
1.18
0.82
PE (p-36:1) or PE (o-36:2)
ME118739
1.18
0.82
PC (30:1)
ME118718
1.17
0.83
1_SM (d35:1) iSTD
ME118704
1.17
0.83
1_LPC (17:0) iSTD
ME118697
1.17
0.83
1_PC (25:0) iSTD
ME118702
1.17
0.83
PE (p-34:1) or PE (o-34:2)
ME118738
1.16
0.84
Ceramide (d42:2)
ME118710
1.16
0.84
PE (32:1)
ME118732
1.16
0.84
PC (38:4) B
ME118723
1.10
0.90
1_Ceramide C17 iSTD
ME118690
1.09
0.91
Gal-Gal-Cer(d18:1/16:0) or Lactosylceramide(d18:1/16:0)
ME118711
1.08
0.92
PE (p-36:2) or PE (o-36:3)
ME118740
1.06
0.94
PC (40:2)
ME118725
1.03
0.97
1_CE (22:1) iSTD
ME118687
1.05
0.95
1_CUDA (pos) iSTD
ME118692
1.04
0.96
PC (42:2)
ME118727
1.04
0.96
PC (38:2)
ME118722
0.99
1.01
GlcCer (d42:2)
ME118714
1.01
0.99
PC (p-36:1) or PC (o-36:2)
ME118730
1.01
0.99
Factors:
F1
Treatment:Control
F2
Treatment:Lipid Supplement
Data matrix
UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
Terms of use
Site map
Contact
NMDR Personnel